|
|
【答案】应助回帖
★ ★ ★ ★ ★ ★ 爱与雨下: 金币+1 2017-10-08 15:02:26 withoutsun(fjtony163代发): 金币+5, 代发 2017-11-15 17:02:45 fjtony163: 翻译EPI+1, 代发 2017-11-15 17:02:52
Further characterization of altered microbiota in patients with inflammatory bowel diseases and linking dysbiosis with host genetic alterations in immunoregulation, innate microbial killing and barrier function are critical, so that individualized treatments to increase beneficial commensals and their metabolic products (probiotic and prebiotic administration) and diminish deleterious species such as adherent/invasive E. coli can be tailored for defined patient subsets.
进一步阐明炎症性结肠病患者微生物丛的改变及生态失调与免疫调节的宿主遗传改变、先天性微生物杀伤和屏障功能之间的联系至关重要,有助于对特定患者亚群进行特定的个性化治疗以增加有益共生菌及其代谢产物(益生菌和促生素治疗)和减少有害菌类如粘附/侵袭性大肠杆菌。 |
|